| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |